Basal Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Basal Insulin (Long Acting Insulin) Market is segmented into Products (Lantus, Levemir, Tresiba, Toujeo, Basaglar) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The market values are provided in terms of (in USD million) and volume (in million mL) for the above segments.

Basal Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Basal Insulin Industry Overview

The Global Basal Insulin (Long-acting Insulin) Market is consolidated, with a few major manufacturers having a global market presence and occupying a major share, like Eli Lilly, Boehringer Ingelheim, Sanofi, Biocon, etc.

Basal Insulin Market Leaders

  1. Novo Nordisk

  2. Sanofi

  3. Eli Lilly

  4. Biocon

  5. Wockhardt

  6. *Disclaimer: Major Players sorted in no particular order
Basal Insulin Market Concentration

Long Acting Insulin Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?